Greenslopes, Australia

Jeanette Elizabeth Stok

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jeanette Elizabeth Stok

Introduction

Jeanette Elizabeth Stok, an accomplished inventor based in Greenslopes, Australia, has made notable contributions to the field of biotechnology. With two patents to her name, her innovations focus on enhancing the capabilities of chaperonin 10 polypeptides, which play a critical role in cellular processes.

Latest Patents

Her latest patents include "Modified Cpn10 and PRR Signalling" and "Chaperonin 10 Variants." The first invention relates to isolated Cpn10 polypeptides that exhibit increased affinity for a PRR ligand compared to the standard Ala Cpn10 polypeptide. It explores the potential of modified chaperonin 10 polypeptides, as well as the nucleic acids that encode them, and their various applications. The second patent discusses N-terminal variants of chaperonin 10, which have enhanced immunomodulatory capacities and improved binding affinities for pathogen-associated and damage-associated molecular patterns. These innovations hold significant promise for advancements in immunology and therapeutic applications.

Career Highlights

Jeanette is currently employed at Cbio Limited, where she leverages her expertise to drive research and development in biotechnological advancements. Her work focuses on bridging gaps in current scientific knowledge and creating solutions that can improve health outcomes.

Collaborations

Throughout her career, Jeanette has collaborated with notable colleagues, including Dean Jason Naylor and Richard James Brown. Together, they contribute to pioneering research that pushes the boundaries of biotechnology.

Conclusion

Jeanette Elizabeth Stok stands out as a significant contributor to the field of biotechnology with her innovative patents and collaborative efforts. Her focus on enhancing chaperonin 10 polypeptides opens new avenues for research, impacting both academia and industry. As her career progresses, her contributions are set to influence the future of immunological research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…